Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Xue

Showing results (301-310 of 623) with videos related to

Pageof 63
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|March 19, 2020
RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9Jun Xue, Xueliang Wu, Ming Qu, et al.
RSC Advances|August 3, 2022
A novel metal-organic framework of Ba-hemin with enhanced cascade activity for sensitive glucose detectionJintao Yi, Xianqin Han, Fengying Gao, et al.
Yi Chuan = Hereditas|December 28, 2005
[Research on the polymorphism of heart fatty acid-binding protein gene in Shanxi pig breeds and their crossbred populations using PCR-RFLP]Wen-Ping Yang, Guo-Qing Cao, Shang-Jun Xue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 22, 2014
miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3Jun Xue, Yan-Feng Niu, Jing Huang, et al.
Cancer Pathogenesis and Therapy|March 20, 2026
Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation studyYongqiang Yang, Jing Tang, Zilong Wu, et al.
Journal of Cellular and Molecular Medicine|November 10, 2018
Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cellYibing Si, Junfeng Liu, Hongliang Shen, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|November 3, 2021
[Expression of Runt-related Transcription Factor 3 in Human Colon Cancer Cell Line HCT-116 Resistant to 5-Fluorouracil and the Mechanism of Drug Resistance]Shuang Fan, Xue-Liang Wu, Jun Xue, et al.
Current Medical Science|April 28, 2023
Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient SamplesSi-Si Zhang, Jin-Feng Zhang, Jing-Qiong Wang, et al.
BMC Cancer|December 15, 2018
Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case reportZhenyu Lin, Junli Liu, Li Peng, et al.
Molecules (Basel, Switzerland)|July 13, 2018
Influence of Extraction Conditions on Ultrasound-Assisted Recovery of Bioactive Phenolics from Blueberry Pomace and Their Antioxidant ActivityBio Sigui Bruno Bamba, John Shi, Carole C Tranchant, et al.
Pageof 63

Showing results (301-310 of 623) with videos related to

Sort By:
Pageof 63
Evidence-Based Complementary and Alternative Medicine : Ecam|March 19, 2020
RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9Jun Xue, Xueliang Wu, Ming Qu, et al.
RSC Advances|August 3, 2022
A novel metal-organic framework of Ba-hemin with enhanced cascade activity for sensitive glucose detectionJintao Yi, Xianqin Han, Fengying Gao, et al.
Yi Chuan = Hereditas|December 28, 2005
[Research on the polymorphism of heart fatty acid-binding protein gene in Shanxi pig breeds and their crossbred populations using PCR-RFLP]Wen-Ping Yang, Guo-Qing Cao, Shang-Jun Xue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 22, 2014
miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3Jun Xue, Yan-Feng Niu, Jing Huang, et al.
Cancer Pathogenesis and Therapy|March 20, 2026
Safety and efficacy of JWATM204, a novel Glypican-3 (GPC3)-targeted CAR T cell therapy for advanced hepatocellular carcinoma: A phase I dose-escalation studyYongqiang Yang, Jing Tang, Zilong Wu, et al.
Journal of Cellular and Molecular Medicine|November 10, 2018
Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cellYibing Si, Junfeng Liu, Hongliang Shen, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|November 3, 2021
[Expression of Runt-related Transcription Factor 3 in Human Colon Cancer Cell Line HCT-116 Resistant to 5-Fluorouracil and the Mechanism of Drug Resistance]Shuang Fan, Xue-Liang Wu, Jun Xue, et al.
Current Medical Science|April 28, 2023
Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient SamplesSi-Si Zhang, Jin-Feng Zhang, Jing-Qiong Wang, et al.
BMC Cancer|December 15, 2018
Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case reportZhenyu Lin, Junli Liu, Li Peng, et al.
Molecules (Basel, Switzerland)|July 13, 2018
Influence of Extraction Conditions on Ultrasound-Assisted Recovery of Bioactive Phenolics from Blueberry Pomace and Their Antioxidant ActivityBio Sigui Bruno Bamba, John Shi, Carole C Tranchant, et al.
Pageof 63